Profiling UK injectable aesthetic practitioners: A national cohort analysis
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2023
DOI: 10.1016/j.bjps.2023.06.057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2023. Verfasst von David Zargaran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, University College London, London, UK. Electronic address: d.zargaran@ucl.ac.uk. Hauptthemen laut MEDLINE: Physicians, Plastic Surgery Procedures. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: The United Kingdom (UK) injectables market has been growing rapidly with a lack of robust regulation and to date, no information regarding the profile of practitioners has been published. AIM: We aim to provide a descriptive and qualitative analysis of the advertised practitioners in the United Kingdom. METHODS: We performed a systematic search using the internet search engine Google to perform a qualitative descriptive analysis of aesthetic practitioners in the UK. For each contiguous country in the UK: England, Scotland, and Wales, five searches were performed. The list of practitioners was then cross-referenced with professional regulatory bodies, with extraction of registration number, date of registration and presence or absence from the Specialist Register or General Practitioner Register. RESULTS: 3000 websites were visited and evaluated. 1224 independent clinics with 4405 practitioners were identified. 738 were identified as those in business support functions and the remaining 3667 practitioners were undertaking injectable practice. The profile of professions were doctors 32%, nurses 13%, dentists 24% and dental nurses 8%. Of the 1163 doctors identified 481 were on the specialist register (41%) and 219 were on the GP register (19%). 27 specialties were represented in this cohort analysis. Plastic Surgery formed the majority of those who were on the specialist register at 37%, followed by Dermatology at 18%. CONCLUSION: This paper is the first to describe the range of practitioners, their professional backgrounds and experience who perform non-surgical aesthetic interventions. The range of backgrounds may have an impact on the potential risks to patients and will be an important consideration in proposed legislation to introduce licensing to the industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery, University College London, London, UK. Electronic address: d.zargaran@ucl.ac.uk.
- Department of Plastic Surgery, University College London, London, UK.
- QUAD A - American Association for the Accreditation of Ambulatory Plastic Surgery Facilities (AAAAPSF), IL, USA.
- UCL Global Business School for Health, University College London, London, UK.
- Department of Computer Science, University College London, London, UK; Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany.
Zitieren
APA
Zargaran, D., Zargaran, A., Terranova, T., Khaledi, H., Robinson, A., Davies, J., Weyrich, T., & Mosahebi, A. (2023). Profiling UK injectable aesthetic practitioners: A national cohort analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2023.06.057
Vancouver
Zargaran D, Zargaran A, Terranova T, Khaledi H, Robinson A, Davies J, et al. Profiling UK injectable aesthetic practitioners: A national cohort analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2023. doi:10.1016/j.bjps.2023.06.057
BibTeX
@article{Zargaran2023,
author = {Zargaran, David and Zargaran, Alexander and Terranova, Tom and Khaledi, Helia and Robinson, Alexandra and Davies, Julie and Weyrich, Tim and Mosahebi, Afshin},
title = {Profiling UK injectable aesthetic practitioners: A national cohort analysis},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2023},
doi = {10.1016/j.bjps.2023.06.057}
}
EUVIMED